Federal Register / Vol. 74, No. 128 / Tuesday, July 7, 2009 / Notices 32169 

the impact of each of the programs. The 

evaluation tools are primarily protocols 

for conducting interviews with various 

staff of the three programs and 

stakeholders associated with the 

programs. The interview protocols were 

tested during a pilot study in 2008. 

There is also a self-administered form 

for each of the programs to be 

completed by Executive Directors or 

his/her designee. The self-administered 

form was developed as a result of the 

pilot study and, therefore, has not been 

tested for reliability and validity. It is 

intended that the clearance process will 

be a mechanism for determining the 

reliability, validity, and feasibility of 

using this instrument. 

Respondents: Staff of State Councils 

on Developmental Disabilities, State 

Protection and Advocacy Systems for 

Individuals with developmental 

disabilities, and University Centers for 

Excellence in Developmental 

Disabilities, Education, Research, and 

Service; individuals with 

developmental disabilities; parents of 

individuals with developmental 

disabilities; siblings of individuals with 

developmental disabilities; guardians; 

advocates; policymakers; service 

providers; university faculty; and others 

(e.g., DDC chairs, members of Protection 

and Advocacy boards of directors or 

commissioners; Consumer Advisory 

Committee members) 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

DD Council: Executive Director Interview ...................................................... 20 1 4 80 

DD Council: Interview with Council Chair/Council Members ........................ 60 1 0 .75 45 

DD Council: Group Interview with Policymakers, Collaborators, and Grantees .............................................................................................................. 160 1 2 320 

UCEDD: Telephone Interview with Current and Graduated Students .......... 100 1 0 .75 75 

UCEDD: Interview with the Consumer Advisory Committee ......................... 60 1 0 .75 45 

UCEDD: Interview with Peer Researchers and Colleagues ......................... 100 1 0 .75 75 

UCEDD: Interview with Recipients of Community Services or Members of 

Organizations/Agencies that Are Trained To Provide Community Services ............................................................................................................. 100 1 0 .75 75 

UCEDD: Self-administered Form ................................................................... 20 1 8 160 

P&A: Executive Director Interview ................................................................. 20 1 4 80 

P&A: Staff Interview ....................................................................................... 60 1 0 .75 45 

P&A: Board of Directors (Commissioners)—Chair and Members ................ 60 1 0 .75 45 

P&A: Group Interview with Policymakers and Collaborators ........................ 160 1 2 320 

P&A: Interview with Recipient of Community Education ............................... 100 1 0 .75 75 

P&A: Interview with Clients ........................................................................... 100 1 0 .75 75 

P&A: Self-administered Form ........................................................................ 20 1 8 160 

UCEDD: Interview with Director .................................................................... 20 1 4 80 

DD Council: Group Interview with Recipients of Self-Advocacy and Leadership Education and Training ................................................................... 100 1 0 .75 75 

DD Council: Group Interview with Recipients of Education and Training to 

Improve Community Capacity .................................................................... 100 1 0 .75 75 

DD Council: Self-administered Form ............................................................. 20 1 8 160 

DD Council Estimate of Total Burden Hours for Activities to Support Administration of Proposed Information Collection Instruments .................... 20 1 33 .50 670 

P&A Estimate of Total Burden Hours for Activities to Support Administration of Proposed Information Collection Instruments ................................. 20 1 33 .50 670 

UCEDD Estimate of Total Burden Hours for Activities to Support Administration of Proposed Information Collection Instruments ............................. 20 1 33 .50 670 

Estimated Total Annual Burden 

Hours: 4,075. 

Additional Information: 

Copies of the proposed collection may 

be obtained by writing to the 

Administration for Children and 

Families, Office of Administration, 

Office of Information Services, 370 

L’Enfant Promenade, SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. All requests should be 

identified by the title of the information 

collection. E-mail address: 

infocollection@acf.hhs.gov. 

OMB Comment: 

OMB is required to make a decision 

concerning the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. Written comments and 

recommendations for the proposed 

information collection should be sent 

directly to the following: 

Office of Management and Budget, 

Paperwork Reduction Project, Fax: 202– 

395–7245, Attn: Desk Officer for the 

Administration for Children and 

Families. 

Dated: June 30, 2009. 

Janean Chambers, 

Reports Clearance Officer. 

[FR Doc. E9–15841 Filed 7–6–09; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

32170 Federal Register / Vol. 74, No. 128 / Tuesday, July 7, 2009 / Notices 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism. Special 

Emphasis Panel Alcohol Pharmacotherapy 

and the Treatment and Prevention of HIV/ 

AIDS. (RFA AA 09 007/008) and Other AIDS 

Related Research. 

Date: August 6, 2009. 

Time: 8 a.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5635 

Fishers Lane, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: Katrina L Foster, PhD, 

Scientific Review Officer, National Inst on 

Alcohol Abuse & Alcoholism, National 

Institutes of Health, 5635 Fishers Lane, Rm. 

2019, Rockville, MD 20852. 301–443–4032. 

katrina@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants; 

93.701, ARRA Related Biomedical Research 

and Research Support Awards, National 

Institutes of Health, HHS) 

Dated: June 29, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–15847 Filed 7–6–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences. Special Emphasis 

Panel Minority Biomedical Research 

Support. 

Date: July 19–20, 2009. 

Time: 7 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, Bethesda, MD 20814. 

Contact Person: Margaret J. Weidman, PhD, 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 45 

Center Drive, Room 3AN18B, Bethesda, MD 

20892. 301–594–3663. 

weidmanma@nigms.nih.gov. 

Name of Committee: National Institute of 

General Medical Sciences. Special Emphasis 

Panel MBRS Score. 

Date: July 20–21, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, Bethesda, MD 20814. 

Contact Person: Lisa Dunbar, PhD, 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 45 

Center Drive, Room 3AN12, Bethesda, MD 

20892. 301–594–2849. dunbarl@mail.nih.gov. 

Name of Committee: National Institute of 

General Medical Sciences. Special Emphasis 

Panel New Innovator Awards. 

Date: July 21, 2009. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892. (Telephone Conference Call). 

Contact Person: Richard T. Okita, PhD, 

Program Director, Pharmacological and 

Physiological Sciences Branch, National 

Institute of General Medical Sciences, 

National Institutes of Health, Natcher 

Building, Room 2A5–49, Bethesda, MD 

20892. 301–594–4469. okitar@nigms.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: June 29, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–15846 Filed 7–6–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institutes of Health Guidelines 

for Human Stem Cell Research 

SUMMARY: The National Institutes of 

Health (NIH) is hereby publishing final 

‘‘National Institutes of Health 

Guidelines for Human Stem Cell 

Research’’ (Guidelines). 

On March 9, 2009, President Barack 

H. Obama issued Executive Order 

13505: Removing Barriers to 

Responsible Scientific Research 

Involving Human Stem Cells. The 

Executive Order states that the Secretary 

of Health and Human Services, through 

the Director of NIH, may support and 

conduct responsible, scientifically 

worthy human stem cell research, 

including human embryonic stem cell 

(hESC) research, to the extent permitted 

by law. 

These Guidelines implement 

Executive Order 13505, as it pertains to 

extramural NIH-funded stem cell 

research, establish policy and 

procedures under which the NIH will 

fund such research, and helps ensure 

that NIH-funded research in this area is 

ethically responsible, scientifically 

worthy, and conducted in accordance 

with applicable law. Internal NIH 

policies and procedures, consistent with 

Executive Order 13505 and these 

Guidelines, will govern the conduct of 

intramural NIH stem cell research. 

DATES: Effective Date: These Guidelines 

are effective on July 7, 2009. 

Summary of Public Comments on 

Draft Guidelines: On April 23, 2009 the 

NIH published draft Guidelines for 

research involving hESCs in the Federal 

Register for public comment, 74 FR 

18578 (April 23, 2009). The comment 

period ended on May 26, 2009. 

The NIH received approximately 

49,000 comments from patient advocacy 

groups, scientists and scientific 

societies, academic institutions, medical 

organizations, religious organizations, 

and private citizens. The NIH also 

received comments from members of 

Congress. This Notice presents the final 

Guidelines together with the NIH 

response to public comments that 

addressed provisions of the Guidelines. 

Title of the Guidelines, Terminology, 

and Background 

Respondents felt the title of the NIH 

draft guidelines was misleading, in that 

it is entitled ‘‘National Institutes of 

Health Guidelines for Human Stem Cell 

Research,’’ yet addresses only one type 

of human stem cell. The NIH notes that 

although the Guidelines pertain 

primarily to the donation of embryos for 

the derivation of hESCs, one Section 

also applies to certain uses of both 

hESCs and human induced pluripotent 

stem cells. Also, the Guidelines discuss 

applicable regulatory standards when 

research involving human adult stem 

cells or induced pluripotent stem cells 

constitutes human subject research.